Skip to main content
. 2012 Jul 13;7(7):e40794. doi: 10.1371/journal.pone.0040794

Figure 1. In vivo development of MCF-7 Tet-Off/ACSL4 tumor xenografts.

Figure 1

(A) Comparison of average tumor volume of MCF-7 Tet-Off/ACSL4 and MCF-7 Tet-Off empty vector tumor xenografts 70 days after injection of 5×106 cells into the right flank of female Balb/c nu/nu mice, aged 6–8 weeks. Each point represents mean ± SD, n = 5. GraphPad Prism Software was used to performed a two-way ANOVA, post test Bonferroni. (*) P<0.05; (***) P<0.001. (B) A representative photograph of mice carrying MCF-7 Tet-Off/ACSL4 and MCF-7 Tet-Off empty vector tumors.